Limited-Time September Offer: Try 7 Days for Free

Incyte Corporation (0J9P.L) Stock Price

$83.86 0.8%

Sign up
to add to portfolio

AI Score

  • Alternative

    7
  • Fundamental

    7
  • Technical

    5

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.

Sign up to get access to more historical data and insights on Incyte Corporation, AI stock picks, stock alerts and much more.

Sign up

0J9P.L AI Stock Analysis

AI stock analysis for 0J9P.L is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Incyte Corporation (0J9P.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Incyte Corporation (0J9P.L) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Incyte Corporation (0J9P.L), currently trading at $83.86, will... Sign up to access price prediction.

About 0J9P.L

LSE
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally.

  • Symbol

    0J9P.L

  • Market

    LSE

  • Industry

    Medical - Pharmaceuticals

  • Market Cap

    16.4B

0J9P.L Alternative Data

Web Traffic

Incyte Corporation receives an estimated 100427 monthly visitors to incyte.com.

  • Web Traffic

    100427

  • Change from Previous Month

    43.8%

  • 3 Month Change

    75.6%

  • YoY Change

    75.6%

Twitter Followers

Incyte Corporation has 6,463 Twitter Followers on its main Twitter (also known as X) account.

  • Twitter Followers

    6463

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0.5%

  • YoY Change

    0.5%

Facebook Engagement

Incyte Corporation has engaged 77 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    77

  • Daily Change

    0%

  • 1 Month Change

    65.2%

  • 3 Month Change

    90.2%

  • YoY Change

    90.2%

Instagram Followers

Incyte Corporation has 2,024 Instagram Followers on its main Instagram account, up by 5.5% over the last month.

  • Instagram Followers

    2024

  • Daily Change

    0.3%

  • 1 Month Change

    5.5%

  • 3 Month Change

    17.2%

  • YoY Change

    17.2%

Youtube Subscribers

Incyte Corporation has 277 subscribers on its main Youtube channel, up by 0.4% over the last month.

  • Youtube Subscribers

    277

  • Daily Change

    0.4%

  • 1 Month Change

    0.4%

  • 3 Month Change

    3.7%

  • YoY Change

    3.7%

Job Postings

Incyte Corporation currenly has an estimated 166 open job postings, up by 50.9% over the last month.

  • Job Postings

    166

  • Daily Change

    0%

  • 1 Month Change

    50.9%

  • 3 Month Change

    32.8%

  • YoY Change

    32.8%

Reddit Mentions

Incyte Corporation has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

LinkedIn Followers

122,728 are following Incyte Corporation on LinkedIn, up by 1.7% over the last month.

  • LinkedIn Followers

    122728

  • Daily Change

    1.7%

  • 1 Month Change

    1.7%

  • 3 Month Change

    6.4%

  • YoY Change

    6.4%

LinkedIn Employees

According to LinkedIn, Incyte Corporation has 3,194 employees, down by -0.1% over the last month.

  • LinkedIn Employees

    3194

  • Daily Change

    0.1%

  • 1 Month Change

    0.1%

  • 3 Month Change

    1.5%

  • YoY Change

    1.5%

Business Outlook

According to employee reviews, the business outlook among employees at Incyte Corporation is 63 out of 100 (bullish).

  • Business Outlook

    63

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

News Mentions

Incyte Corporation was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    100%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

0J9P.L Financials

0J9P.L Key Metrics
  • Total Revenue

    $1.1B

  • Net Income

    $158.2M

  • Earnings per Share

    $0.82

  • Free cash flow

    $262.9M

  • EBITDA

    $205.2M

  • EBITDA Ratio

    0.19486

  • Total Assets

    $5.7B

0J9P.L 2-year Revenue & Income
0J9P.L 2-year Free Cash Flow

0J9P.L Technicals

0J9P.L SMA
0J9P.L RSI

FAQ

What's the current price of Incyte Corporation (0J9P.L) Stock?
The price of an Incyte Corporation (0J9P.L) share is $83.86.

What's the market cap of Incyte Corporation?
The current market cap of Incyte Corporation is 16.4B.

What are some stocks similar to Incyte Corporation (0J9P.L) that investors often compare it to?
Incyte Corporation (0J9P.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Esperion Therapeutics.

What is the forecast for Incyte Corporation's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Incyte Corporation's stock price to be around $90.39 in 2026. Starting from the current price of $83.86, this represents a 7.8% change in price, indicating a bullish outlook for the stock.

How to buy Incyte Corporation (0J9P.L) Stock?
Incyte Corporation stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Incyte Corporation shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.